ZAZA ANTONIO
- U03, Floor: 3, Room: 3011
Publications
Cruz, A., Ronchi, C., Bartolucci, C., Socuellamos, P., Benito-Bueno, A., Severi, S., et al. (2025). RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels. BIOMÉDECINE & PHARMACOTHÉRAPIE, 187(June 2025) [10.1016/j.biopha.2025.118083]. Detail
Maione, A., Iengo, L., Sala, L., Massaiu, I., Chiesa, M., Lippi, M., et al. (2024). Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling. CELL DEATH DISCOVERY, 10(1) [10.1038/s41420-024-02232-8]. Detail
Maniezzi, C., Bastaroli, F., Dusi, V., Florindi, C., Eskandr, M., Anzaldi, I., et al. (2024). Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2. VASCULAR PHARMACOLOGY, 155(June 2024) [10.1016/j.vph.2024.107329]. Detail
Bossi, E., Nobile, M., Ferrara, A., Reveglia, P., Corso, G., Malfatto, G., et al. (2024). Optimizing blood microsampling protocols for metabolomics and lipidomics: Application in a rehabilitomics study. Intervento presentato a: 9° Congresso Nazionale SIPMeL 2024, Riva del Garda, Italia. Detail
Bossi, E., Paoletti, F., Denti, V., Limo, E., Serrao, S., Malfatto, G., et al. (2024). Blood microsampling for untargeted metabolomics: a preliminary study on patients affected by myocardial infarction. Intervento presentato a: XXVIII CONGRESSO NAZIONALE SCI (Società Chimica Italiana), Milano, Italia. Detail